KOR

e-Article

SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas – Aiming to improve therapy, outcomes, and validate a prospective frailty tool
Document Type
Article
Source
In Journal of Geriatric Oncology March 2022 13(2):258-264
Subject
Language
ISSN
1879-4068